Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Novo Biosciences

Novo Biosciences

A pharmaceutical company that uses a zebrafish drug-screening platform to find drug candidate molecules that have the capacity to promote regeneration of tissues. Their drug candidate MSI-1436 is being developed and tested for the treatment of heart disease, Duchenne Muscular Dystrophy and diabetic nephropathy.

All edits

Edits on 27 Jul, 2022
Golden AI"remove blacklisted domain URLs"
Golden AI edited on 27 Jul, 2022
Infobox
Golden AI"remove blacklisted domain URLs"
Golden AI edited on 27 Jul, 2022
Infobox
Edits on 3 Jul, 2022
Anastasiia Polysaeva"Edit from table cell"
Anastasiia Polysaeva edited on 3 Jul, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Full address
One City Hall Plaza Ellsworth, ME 04605 United States
Anastasiia Polysaeva"Edit from table cell"
Anastasiia Polysaeva edited on 3 Jul, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 24 Jun, 2022
Duzenko Andrey
Duzenko Andrey edited on 24 Jun, 2022
Edits made to:
Infobox (+2 properties)
Infobox
Founder
Duzenko Andrey
Duzenko Andrey edited on 24 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 25 May, 2022
Petrov Daniil
Petrov Daniil edited on 25 May, 2022
Edits made to:
Infobox (+1 properties)
Infobox
B2X
Edits on 20 May, 2022
Ирина Носкова"Edit from table cell"
Ирина Носкова edited on 20 May, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Company Operating Status
Active
Edits on 16 May, 2022
Katrina-Kay Alaimo"prospector:1525:714594"
Katrina-Kay Alaimo edited on 16 May, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 7 Aug, 2021
Golden AI"Inferring industry - ai.industry_clf.02"
Golden AI edited on 7 Aug, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI"Inferring industry - ai.industry_clf.02"
Golden AI edited on 7 Aug, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 16 Jun, 2021
Erin Scherfner"prospector:332:163024"
Erin Scherfner edited on 16 Jun, 2021
Edits made to:
Infobox (+2 properties)
Infobox
Edits on 5 Mar, 2021
Golden AI"Auto-imported"
Golden AI edited on 5 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
D-U-N-S Number
078868103
Edits on 23 Feb, 2021
Golden AI"Setting founded date to the company's date of incorporation."
Golden AI edited on 23 Feb, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Founded date
2013
Edits on 6 Oct, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 6 Oct, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding round date
June 2020
Edits on 9 Jun, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 9 Jun, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Total funding amount (USD)
4,000,000
Golden AI
Golden AI edited on 9 Jun, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 14 Sep, 2019
Julius John Villarisco
Julius John Villarisco approved a suggestion from Golden's AI on 14 Sep, 2019
Edits made to:
Article (+6/-6 characters)
Article

Voot Yin, Novo Bioscience’s chief scientific officer was awarded a two-year $1.5 million Small Business Innovation Research grant in 2017 from the National Heart, Lung and Blood Institute, an institute of the National Institutes of HealthHealth (NIH), to study trodusquemine in the pig. The pig heart closely resembles that of a human. The drug is being tested as a treatment for acute heart attack and also for chronic heart injury, Duchenne muscular dystrophy, skeletal muscle injury and spinal cord damage.

Julius John Villarisco
Julius John Villarisco approved a suggestion from Golden's AI on 14 Sep, 2019
Edits made to:
Article (+15/-15 characters)
Article

Novo Biosciences was founded by Kevin Strange and Voot P. Yin. Strange was president of Mount Desert Island (MDI) Biological Lab from 2009 to 2016 and and Yin was an MDI Biological Laboratory faculty member. Together along with Michael ZasloffMichael Zasloff of Georgetown University, they are co-inventors of the drug candidate MSI-1436, also called trodusquemine. Strange stepped down as president of MDI Bio Lab to pursue development of MSI-1436 as CEO of Novo Biosciences.

Julius John Villarisco
Julius John Villarisco approved a suggestion from Golden's AI on 14 Sep, 2019
Edits made to:
Article (+4/-4 characters)
Article

Voot Yin, Novo Bioscience’s chief scientific officer was awarded a two-year $1.5 million Small Business Innovation Research grant in 2017 from the National Heart, LungLung and Blood Institute, an institute of the National Institutes of Health (NIH), to study trodusquemine in the pig. The pig heart closely resembles that of a human. The drug is being tested as a treatment for acute heart attack and also for chronic heart injury, Duchenne muscular dystrophy, skeletal muscle injury and spinal cord damage.

Golden logo
By using this site, you agree to our Terms & Conditions.